Tuberculosis (TB) is the leading infectious cause of mortality worldwide, due in part to a
limited understanding of its clinical pathogenic spectrum of infection and disease …

Abstract Background. Multidrug-resistant (MDR) tuberculosis (TB) has emerged as a global
epidemic, with∼ 425,000 new cases estimated to occur annually. The global human …

This report updates and combines earlier versions of guidelines for the prevention and
treatment of opportunistic infections (OIs) in HIV-infected adults (ie, persons aged> 18 years) …

Background The World Health Organization recommends the screening of all people living
with HIV for tuberculosis (TB) disease, followed by TB treatment, or isoniazid preventive …

Background Tuberculosis screening is recommended for people with human
immunodeficiency virus (HIV) infection to facilitate early diagnosis and safe initiation of …

Objective: To determine the short-term and long-term risks of tuberculosis (TB) associated
with CD4 cell recovery during antiretroviral therapy (ART). Design: Observational community …

Despite policies, strategies, and guidelines, the epidemic of HIV-associated tuberculosis
continues to rage, particularly in southern Africa. We focus our attention on the regions with …

Background: Tuberculosis is a common complication and leading cause of death in HIV
infection. Antiretroviral therapy (ART) lowers the risk of tuberculosis, but may not be sufficient …

Tuberculosis is the main cause of morbidity and mortality in people living with HIV/AIDS
worldwide. Early diagnosis and treatment is essential to addressing the dual epidemic of …

Human immunodeficiency virus (HIV) associated tuberculosis (TB) remains a major global
public health challenge, with an estimated 1.4 million patients worldwide. Co-infection with …